March 22, 2018 / 7:31 AM / 8 months ago

BRIEF-Deinove Signs License Option Agreement With Redx Pharma

March 22 (Reuters) - DEINOVE SA:

* DEINOVE EXPANDS ITS INNOVATIVE ANTIBIOTIC PORTFOLIO BY SIGNING A LICENSE OPTION AGREEMENT WITH REDX PHARMA

* PROGRAM DEVELOPED BY REDX PHARMA FOCUSES ON A NEW CLASS OF ANTIBIOTICS AIMED AT TREATING MOST LETHAL INFECTIONS

* DEINOVE ACQUIRES AN OPTION FOR A LICENSE ON A SERIES OF MOLECULES ABOUT TO ENTER PRECLINICAL DEVELOPMENT.

* REDX PHARMA ENTRUSTS DEINOVE WITH NEXT STEPS TO OPTIMIZE ITS ANTI-INFECTIVE PROGRAM. Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below